Sept 9 (Reuters) - Medtronic (NYSE:MDT) PLC MDT.N :
* MEDTRONIC RECEIVES BREAKTHROUGH DEVICE DESIGNATION FROM FDA, BEGINS EARLY FEASIBILITY STUDY FOR INVESTIGATIONAL INTREPID™ TRANSCATHETER VALVE SYSTEM FOR THE TREATMENT OF TRICUSPID VALVE REGURGITATION